Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by trail/Apo2L

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 11128-11136

  Lum, J J ^a   Pilon, A A ^a   Sanchez Dardon, J ^a   Phenix, B N ^a   Kim, J E ^a   Mihowich, J ^a   Jamison, K ^a   Hawley Foss, N ^a   Lynch, D H ^a   Badley, A D ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; HLA DR ANTIGEN; LEUCINE ZIPPER PROTEIN; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS DNA; VIRUS RNA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT VIRUS INFECTION; MACROPHAGE; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROVIRUS; RNA SYNTHESIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; JURKAT CELLS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, VIRAL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034765429     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.11128-11136.2001     Document Type: Article

References (53)

1. Safety and antitumor activity of recombinant soluble Apo2 ligand
2. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
3. Mechanisms of HIV associated lymphocyte apoptosis
4. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
5. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
6. + T cells during primary HIV-1 infection
7. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
8. Latent reservoirs of HIV: Obstacles to the eradication of virus
9. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
10. Latent reservoirs of HIV infection: Flushing with IL-2?
11. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
12. To die or not to die-the quest of the TRAIL receptors
13. HLA DNA typing
14. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
15. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
16. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
17. Viral dynamics in HIV-1 infection
18. Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1-infected primary lymphocytes
19. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions
20. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11
21. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
22. TRAIL: A molecule with multiple receptors and control mechanisms
23. Functional analysis of TRAIL receptors using monoclonal antibodies
24. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine
25. Ongoing HIV dissemination during HAART
26. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy
27. Quantitative image analysis of HIV-1 infection in lymphoid tissue
28. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells
29. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes
30. Inhibition of death receptor signals by cellular FLIP
31. Diagnosis of HIV-1 group O infection by polymerase chain reaction
32. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
33. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
34. Interleukin-1β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection
35. + T lymphocytopenia
36. An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro
37. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection
38. + T cells in HIV-1-infected hu-PBL-NOD-SCID mice
39. Dilution assay statistics
40. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
41. Lymph node architecture preceding and following 6 months of potent antiviral therapy: Follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient
42. + T cells are infected in human immunodeficiency virus type 1-infected individuals
43. The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection
44. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
45. HIV-1 and HAART: A time to cure, a time to kill
46. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
47. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
48. Measles virus induces functional TRAIL production by human dendritic cells
49. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
50. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
51. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
52. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
53. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma